NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRXP NRX Pharmaceuticals Inc.

休市中 12-06 16:00:00 EST

1.22

+0.03

+2.52%

盘后1.25

+0.03+2.46%

19:50 EST

最高1.22	最低1.17	成交量7.67万
今开1.17	昨收1.19	日振幅4.20%
总市值1,471万	流通市值1,128万	总股本1,206万
成交额9.18万	换手率0.83%	流通股本924.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":1.22,"timestamp":1733518800000,"preClose":1.19,"halted":0,"volume":76739,"hourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.22,"latestTime":"19:50 EST","volume":3055,"amount":3793.4274,"timestamp":1733532612574},"delay":0,"floatShares":9244500,"shares":12060761,"eps":-2.124018,"marketStatus":"休市中","marketStatusCode":7,"change":0.03,"latestTime":"12-06 16:00:00 EST","open":1.17,"high":1.22,"low":1.17,"amount":91844.0284996,"amplitude":0.042017,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.124018,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1733734800000},"adr":0,"adjPreClose":1.19,"preHourTrading":{"tag":"盘前","latestPrice":1.16,"preClose":1.19,"latestTime":"09:05 EST","volume":5,"amount":5.8,"timestamp":1733493941688},"postHourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.22,"latestTime":"19:50 EST","volume":3055,"amount":3793.4274,"timestamp":1733532612574},"volumeRatio":0.37203,"impliedVol":3.2957,"impliedVolPercentile":0.9127},"requestUrl":"/m/hq/s/NRXP","defaultTab":"news","newsList":[{"id":"2488102118","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.55%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488102118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488102118?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:50","pubTimestamp":1733323846,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时50分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.55%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225046a26c6895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225046a26c6895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2488946513","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488946513?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:39","pubTimestamp":1733236757,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时39分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.81%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223917abf2fc92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223917abf2fc92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2486038597","title":"Nrx Pharmaceuticals, Inc.盘中异动 快速上涨5.16%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038597?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:48","pubTimestamp":1732546139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时48分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.16%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522485998e446b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522485998e446b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2484672457","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672457?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:38","pubTimestamp":1731944285,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时38分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.04%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823380598e43499&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823380598e43499&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2483371980","title":"NRX 制药公司公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483371980","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483371980?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:09","pubTimestamp":1731679777,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc   报告本季度调整后每股亏损13美分，高于去年同期的每股-70美分。三位分析师对该季度的平均预期是每股亏损 64 美分。* NRX Pharmaceuticals Inc 公布的季度每股收益为亏损 15 美分。* 该公司当季亏损 162 万美元。* NRX Pharmaceuticals Inc 的股价本季度下跌了 31.4%，今年迄今为止下跌了 74.8%。华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 31.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NRX 制药公司公布本季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2483738553","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738553?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:52","pubTimestamp":1731599559,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时52分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.60%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235239a237fc1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235239a237fc1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","PULM","BK4007"],"gpt_icon":0},{"id":"2483709865","title":"NRX Pharmaceuticals Inc    预计每股亏损 64 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483709865","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483709865?lang=zh_cn&edition=full","pubTime":"2024-11-13 08:03","pubTimestamp":1731456198,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    将于11月14日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对NRX Pharmaceuticals Inc的平均预期是每股亏损64美分。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 31.00 美元，高于上一次收盘价 1.26 美元。11月13日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NRX Pharmaceuticals Inc    预计每股亏损 64 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2482186465","title":"NRX Pharmaceuticals Inc  预计每股亏损 64 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482186465","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482186465?lang=zh_cn&edition=full","pubTime":"2024-11-09 07:50","pubTimestamp":1731109842,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc  预计每股亏损 64 美分 - 财报前瞻NRX Pharmaceuticals Inc NRXP.OQ NRXP.O将于11月14日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。LSEG分析师对NRX Pharmaceuticals Inc的平均预期是每股亏损64美分。华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 31.00 美元，高于上一次收盘价 1.32 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF303:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP"],"gpt_icon":0},{"id":"2481314805","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481314805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481314805?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:15","pubTimestamp":1730740558,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时15分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.05%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105011558ab9f07df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105011558ab9f07df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2479603882","title":"Nrx Pharmaceuticals, Inc.盘中异动 大幅跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479603882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479603882?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:46","pubTimestamp":1730382373,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时46分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.15%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.16%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214613971a38a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214613971a38a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2479178075","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479178075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479178075?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:19","pubTimestamp":1730301573,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日23时19分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.51%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Calcimedica, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4587.03%、1994.30%、104.31%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为100.99%、72.82%、47.63%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030231933971a3451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030231933971a3451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2479454642","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.37%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479454642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479454642?lang=zh_cn&edition=full","pubTime":"2024-10-29 03:50","pubTimestamp":1730145020,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日03时50分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.37%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029035020a1f2eec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029035020a1f2eec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2477235498","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.65%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477235498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477235498?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:11","pubTimestamp":1729609877,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时11分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.65%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022231118971a1a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022231118971a1a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2477669718","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477669718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477669718?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:32","pubTimestamp":1729517527,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时32分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.60%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213207a1e24945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213207a1e24945&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2476795621","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.69%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476795621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476795621?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:05","pubTimestamp":1729173948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时05分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.69%。截至发稿，该股报1.16美元/股，成交量3.5725万股，换手率0.33%，振幅7.48%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017220548a1e169dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017220548a1e169dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2475992427","title":"Nrx Pharmaceuticals, Inc.盘中异动 快速上涨5.83%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992427?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:30","pubTimestamp":1729085449,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时30分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.83%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213049ab6a8e2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213049ab6a8e2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2475027689","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475027689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475027689?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:09","pubTimestamp":1729001391,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时09分，Nrx Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.30%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522095198e3c8d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522095198e3c8d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2475602913","title":"Nrx Pharmaceuticals, Inc.盘中异动 快速上涨5.11%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475602913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475602913?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:04","pubTimestamp":1728914683,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时04分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422044498e3c49d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422044498e3c49d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0},{"id":"2474447177","title":"Nrx Pharmaceuticals, Inc.盘中异动 急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474447177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474447177?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:26","pubTimestamp":1728570415,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时26分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.44%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010222655ab692b07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010222655ab692b07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"gpt_icon":0},{"id":"2473096103","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473096103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473096103?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:38","pubTimestamp":1728308310,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时38分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.84%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072138309719ea1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072138309719ea1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nrxpharma.com","stockEarnings":[{"period":"1week","weight":-0.0687},{"period":"1month","weight":-0.0687},{"period":"3month","weight":-0.2515},{"period":"6month","weight":-0.6199},{"period":"1year","weight":-0.6302},{"period":"ytd","weight":-0.7348}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0284},{"period":"3month","weight":0.1248},{"period":"6month","weight":0.1382},{"period":"1year","weight":0.3264},{"period":"ytd","weight":0.2788}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NRX Pharmaceuticals, Inc.是于2015年5月20日依照特拉华州法律成立的公司，是一家临床阶段的小分子制药公司，开发用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.17342},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.0504},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.073314},{"month":4,"riseRate":0,"avgChangeRate":-0.311577},{"month":5,"riseRate":0.666667,"avgChangeRate":0.013246},{"month":6,"riseRate":0.25,"avgChangeRate":-0.267026},{"month":7,"riseRate":0.5,"avgChangeRate":0.093346},{"month":8,"riseRate":0.25,"avgChangeRate":-0.143251},{"month":9,"riseRate":0.25,"avgChangeRate":-0.121573},{"month":10,"riseRate":0.75,"avgChangeRate":0.062005},{"month":11,"riseRate":0.5,"avgChangeRate":0.112968},{"month":12,"riseRate":0.25,"avgChangeRate":-0.061273}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}